Clinical Studies

Clinical Trials Coordinators

 

Laura Walter, COA
Research Associate I
Phone: 717-531-4696
Email: Lwalter@hmc.psu.edu

Michael Gricoski, BS, MA
Clinical Research Associate
Phone: 717-531-3790
Email: mgricoski@hmc.psu.edu

 

D. Michelle Davis
Administrative Secretary
Phone: 717-531-8783
Email: ddavis4@hmc.psu.edu

 

 

Non-proliferative Diabetic Retinopathy (IRB# 30791)

Status: No-Longer-Recruiting

 

Investigators:

  • Ingrid U. Scott, M.D., M.P.H., Department of Ophthalmology

 

Description:

A study to determine the effects of doxycycline on the light-sensitive tissue at the back of the eye called the retina, and on the progression of diabetic retinopathy in patients with mild to moderate non-proliferative Diabetic Retinopathy.

 

Eligibility:

You may be eligible to participate if you:

  • are 18 years old or older
  • have type 1 or type 2 diabetes
  • have a hemoglobin A1c level less than or equal to 11 percent
  • have 20/40 or better vision in the study eye
  • have mild to moderate diabetic retinopathy

 

 

Additional Study Details:


 

Locations:

Penn State Hershey Eye Center 

 

Contacts:

To see if you are eligible contact:

Mary Hershey

Phone: 717-531-6779

e-mail: mhershey@hmc.psu.edu

 

 

Categories:

  • Diabetes
  • Non-proliferative Diabetes